ReviewCancers2024

Advances in Targeted Therapy: Addressing Resistance to BTK Inhibition in B-Cell Lymphoid Malignancies.

Andres Bravo-Gonzalez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.